Dexamethasone in adults with bacterial meningitis.

被引:717
作者
de Gans, J [1 ]
van de Beek, D [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands
关键词
D O I
10.1056/NEJMoa021334
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Mortality and morbidity rates are high among adults with acute bacterial meningitis, especially those with pneumococcal meningitis. In studies of bacterial meningitis in animals, adjuvant treatment with corticosteroids has beneficial effects. Methods: We conducted a prospective, randomized, double-blind, multicenter trial of adjuvant treatment with dexamethasone, as compared with placebo, in adults with acute bacterial meningitis. Dexamethasone (10 mg) or placebo was administered 15 to 20 minutes before or with the first dose of antibiotic and was given every 6 hours for four days. The primary outcome measure was the score on the Glasgow Outcome Scale at eight weeks (a score of 5, indicating a favorable outcome, vs. a score of 1 to 4, indicating an unfavorable outcome). A subgroup analysis according to the causative organism was performed. Analyses were performed on an intention-to-treat basis. Results: A total of 301 patients were randomly assigned to a treatment group: 157 to the dexamethasone group and 144 to the placebo group. The base-line characteristics of the two groups were similar. Treatment with dexamethasone was associated with a reduction in the risk of an unfavorable outcome (relative risk, 0.59; 95 percent confidence interval, 0.37 to 0.94; P=0.03). Treatment with dexamethasone was also associated with a reduction in mortality (relative risk of death, 0.48; 95 percent confidence interval, 0.24 to 0.96; P=0.04). Among the patients with pneumococcal meningitis, there were unfavorable outcomes in 26 percent of the dexamethasone group, as compared with 52 percent of the placebo group (relative risk, 0.50; 95 percent confidence interval, 0.30 to 0.83; P=0.006). Gastrointestinal bleeding occurred in two patients in the dexamethasone group and in five patients in the placebo group. Conclusions: Early treatment with dexamethasone improves the outcome in adults with acute bacterial meningitis and does not increase the risk of gastrointestinal bleeding.
引用
收藏
页码:1549 / 1556
页数:8
相关论文
共 26 条
[1]   Community-acquired bacterial meningitis: Risk stratification for adverse clinical outcome and effect of antibiotic timing [J].
Aronin, SI ;
Peduzzi, P ;
Quagliarello, VJ .
ANNALS OF INTERNAL MEDICINE, 1998, 129 (11) :862-869
[2]   875 CASES OF BACTERIAL-MENINGITIS .1. CLINICAL-DATA, PROGNOSIS, AND THE ROLE OF SPECIALIZED HOSPITAL DEPARTMENTS [J].
BOHR, V ;
HANSEN, B ;
JESSEN, O ;
JOHNSEN, N ;
KJERSEM, H ;
KRISTENSEN, HS ;
NYBOE, J ;
RASMUSSEN, N .
JOURNAL OF INFECTION, 1983, 7 (01) :21-30
[3]   Glucocorticoids in central nervous system bacterial infection [J].
Coyle, PK .
ARCHIVES OF NEUROLOGY, 1999, 56 (07) :796-801
[4]   ACUTE BACTERIAL-MENINGITIS IN ADULTS - A REVIEW OF 493 EPISODES [J].
DURAND, ML ;
CALDERWOOD, SB ;
WEBER, DJ ;
MILLER, SI ;
SOUTHWICK, FS ;
CAVINESS, VS ;
SWARTZ, MN .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (01) :21-28
[5]  
Enting RH, 1996, J ANTIMICROB CHEMOTH, V38, P777
[6]   CONFIDENCE-INTERVALS RATHER THAN P-VALUES - ESTIMATION RATHER THAN HYPOTHESIS-TESTING [J].
GARDNER, MJ ;
ALTMAN, DG .
BMJ-BRITISH MEDICAL JOURNAL, 1986, 292 (6522) :746-750
[7]   DEXAMETHASONE TREATMENT FOR BACTERIAL-MENINGITIS IN CHILDREN AND ADULTS [J].
GIRGIS, NI ;
FARID, Z ;
MIKHAIL, IA ;
FARRAG, I ;
SULTAN, Y ;
KILPATRICK, ME .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1989, 8 (12) :848-851
[8]   Computed tomography of the head before lumbar puncture in adults with suspected meningitis. [J].
Hasbun, R ;
Abrahams, J ;
Jekel, J ;
Quagliarello, VJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (24) :1727-1733
[9]  
JENNETT B, 1981, MANAGEMENT HEAD INJU, V20
[10]   BACTERICIDAL ACTIVITY AGAINST CEPHALOSPORIN-RESISTANT STREPTOCOCCUS-PNEUMONIAE IN CEREBROSPINAL-FLUID OF CHILDREN WITH ACUTE BACTERIAL-MENINGITIS [J].
KLUGMAN, KP ;
FRIEDLAND, IR ;
BRADLEY, JS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (09) :1988-1992